혈관 접근 시술 세계 시장 규모는 2024년에 913억 5,000만 달러로 평가되었고, 2030년에는 CAGR 5.38%로 1,252억 8,000만 달러에 이를 것으로 예측됩니다.
헬스케어 수요 증가와 만성질환 부담 증가로 인해 혈관 접근 시술 세계 시장은 크게 확대될 것으로 보입니다. 중심정맥카테터, 말초삽입형 중심정맥카테터(PICC), 동정맥루 등의 삽입을 포함한 혈관접근술은 투약, 영양관리, 투석, 채혈에 필수적인 시술입니다. 암, 신장질환, 심혈관질환 등 만성질환으로 인한 입원이 증가함에 따라 효율적이고 장기적인 혈관 접근 솔루션에 대한 필요성이 급증하고 있습니다. 정기적인 의료 개입이 필요한 동반 질환을 앓고 있는 세계 인구의 고령화도 수술 건수 증가에 기여하고 있습니다. 수술 건수 증가, 입원 기간의 장기화, 휴대용 수액 주입 장치를 통한 재택치료에 대한 선호도가 높아지면서 안전하고 신뢰할 수 있으며 삽입이 용이한 바스큘러 액세스 장치에 대한 시장 수요가 가속화되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 913억 5,000만 달러 |
| 시장 규모 : 2030년 | 1,252억 8,000만 달러 |
| CAGR : 2025-2030년 | 5.38% |
| 급성장 부문 | 항생제 정맥내 투여 치료 |
| 최대 시장 | 북미 |
시장은 주목할 만한 기술 혁신과 트렌드에 의해서도 형성되고 있습니다. 항균 코팅, 초음파 유도 삽입 기술 등 카테터 소재와 디자인의 발전으로 감염, 혈전증 등의 합병증이 감소하고 있습니다. 영상기술과 내비게이션 기술이 바스큘러 액세스 시술에 통합되면서 기구 삽입이 더욱 정확해져 삽입 실패율이 감소하고 있습니다. 저침습적 접근 기술로의 전환은 특히 외래 환자 및 외래 환경에서 환자 편의성 향상과 의료비 절감으로 이어지면서 많은 지지를 받고 있습니다. 시장 진출기업들은 대규모 병원과 저자원 환경 모두에 대응할 수 있는 사용하기 쉽고 비용 효율적인 장비를 출시하는 데 주력하고 있습니다. 의료진들 사이에서 기기 선택 및 삽입 프로토콜에 대한 교육과 인식이 높아지면서 시술 성공률과 환자 안전이 더욱 향상되고 있습니다.
이러한 호황에도 불구하고, 세계 바스큘러 액세스 시술 시장에는 몇 가지 과제가 남아있습니다. 첨단 혈관 접근 장비 및 시술과 관련된 높은 비용으로 인해 저소득층이나 자원이 부족한 환경에서 채택이 제한될 수 있습니다. 카테터 관련 혈류 감염(CRBSI), 폐색, 기계적 고장과 같은 장치 관련 합병증은 여전히 심각한 임상적 위험을 초래하고 있습니다. 임상의의 기술 수준이 다양하고, 기관마다 삽입술이 표준화되어 있지 않아 환자 결과에 일관성이 없는 경우가 많습니다. 새로운 혈관 접근 장치의 승인에 대한 엄격한 규제 요건은 제품 출시를 지연시키고 기술 혁신을 저해할 수 있습니다. 또한, 기기의 내구성, 잦은 교체, 환자의 불편함에 대한 우려는 일부 환자 집단에서 채택을 방해할 수 있습니다. 교육 개선, 환자 맞춤형 기기 설계, 지속적인 임상 연구를 통해 이러한 문제를 해결하는 것은 시장의 지속적인 성장을 보장하는 데 매우 중요합니다.
장기적인 혈관 접근이 필요한 만성질환 유병률 증가
바스큘러 액세스 장비에 따른 합병증 발생 위험이 높습니다.
이미지 유도형 혈관 접근 기술 도입 증가
Global Vascular Access Procedures Market was valued at USD 91.35 Billion in 2024 and is expected to reach USD 125.28 Billion by 2030 with a CAGR of 5.38%. The Global Vascular Access Procedures Market is witnessing substantial expansion as a result of increasing healthcare demands and the growing burden of chronic illnesses. Vascular access procedures, which include the insertion of devices such as central venous catheters, peripherally inserted central catheters (PICCs), and arteriovenous fistulas, are critical for administering medications, nutrition, dialysis, and for blood sampling. A rise in hospital admissions for chronic conditions like cancer, kidney disease, and cardiovascular ailments has led to a corresponding surge in the need for efficient and long-term vascular access solutions. The aging global population, which is more prone to comorbidities requiring regular medical interventions, is also contributing to higher procedure volumes. Rising surgical volumes, longer hospital stays, and increasing preferences for home-based care with portable infusion devices are accelerating the market demand for safe, reliable, and easy-to-insert vascular access devices.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 91.35 Billion |
| Market Size 2030 | USD 125.28 Billion |
| CAGR 2025-2030 | 5.38% |
| Fastest Growing Segment | Intravenous Antibiotics Treatment |
| Largest Market | North America |
The market is also shaped by notable technological innovations and trends. Advancements in catheter materials and designs, such as antimicrobial coatings and ultrasound-guided insertion techniques, are reducing complications such as infections and thrombosis. The integration of imaging and navigation technologies into vascular access procedures is making device placement more accurate and reducing the rate of failed insertions. A shift toward minimally invasive access techniques is gaining traction, particularly in outpatient and ambulatory settings, leading to improved patient comfort and reduced healthcare costs. Market participants are focusing on launching user-friendly and cost-effective devices that cater to both high-volume hospitals and low-resource settings. Increasing training and awareness among healthcare providers regarding device selection and insertion protocols is further improving procedural success rates and patient safety.
Despite the positive momentum, several challenges persist in the Global Vascular Access Procedures Market. High costs associated with advanced vascular access devices and procedures can limit their adoption in lower-income or resource-constrained settings. Device-related complications such as catheter-related bloodstream infections (CRBSIs), occlusions, and mechanical failures continue to pose significant clinical risks. Variability in clinician skill levels and lack of standardized insertion techniques across facilities often result in inconsistent patient outcomes. Stringent regulatory requirements for the approval of new vascular access devices may delay product launches and hinder innovation. Moreover, concerns over device durability, frequent replacements, and patient discomfort may discourage adoption in some patient populations. Addressing these challenges through improved training, patient-specific device design, and ongoing clinical studies will be crucial in ensuring sustainable market growth.
Key Market Drivers
Growing Prevalence of Chronic Diseases Requiring Long-term Vascular Access
The growing prevalence of chronic diseases that require long-term vascular access is one of the most significant drivers of the Global Vascular Access Procedures Market. Chronic kidney disease (CKD) alone affects more than 800 million people globally, accounting for over 10% of the world's population, and its prevalence continues to increase, especially in low- and middle-income countries due to rising rates of diabetes and hypertension. A large proportion of CKD patients depend on hemodialysis, which demands reliable vascular access methods such as arteriovenous fistulas, grafts, and central venous catheters. These access points are critical for ensuring efficient dialysis sessions and improving patient survival outcomes.
Cancer incidence is another major factor contributing to market growth. In 2022, there were nearly 20 million new cancer cases and about 9.7 million deaths worldwide. Many cancer patients undergo chemotherapy, targeted therapy, and supportive treatments requiring long-term intravenous access through devices like implantable ports or peripherally inserted central catheters (PICCs). In parallel, the burden of severe infections and sepsis remains extremely high, with 48.9 million cases and 11 million related deaths annually, representing one in every five deaths globally. These cases frequently necessitate prolonged antibiotic administration via secure vascular access devices.
Technological advancements have further strengthened the role of vascular access procedures in chronic disease management. The introduction of antimicrobial-coated catheters, ultrasound-guided insertion techniques, and needle-free connectors has improved safety, reduced infection risks, and extended device longevity. Growing awareness among healthcare providers about early vascular access planning, especially for patients with progressive chronic illnesses, is improving treatment efficiency and patient quality of life. With aging populations and rising comorbidity rates, demand for dependable, long-term vascular access solutions is expected to accelerate, driving substantial market expansion in the years ahead.
Key Market Challenges
High Risk of Complications Associated with Vascular Access Devices
The Global Vascular Access Procedures Market faces a significant challenge due to the high risk of complications associated with vascular access devices, which can impact patient outcomes and limit procedural adoption. Complications such as catheter-related bloodstream infections (CRBSIs), thrombosis, stenosis, hematoma formation, and device malfunction are common concerns that can arise during or after the procedure. Infections remain one of the most critical risks, as they not only lead to increased morbidity but also escalate healthcare costs due to prolonged hospital stays, additional treatments, and the need for device replacement. Thrombosis and stenosis can compromise the efficiency of vascular access, requiring repeat interventions that increase the burden on both healthcare systems and patients. In certain cases, repeated procedures can lead to limited viable access sites, especially in patients undergoing long-term treatments like hemodialysis or chemotherapy.
The risk of complications is amplified in patients with multiple comorbidities, weakened immune systems, or poor vascular health, making device placement and maintenance more challenging. A lack of standardized training protocols for device insertion and maintenance in some regions contributes to procedural variability, which can further elevate complication rates. Concerns about these risks often lead to hesitancy among healthcare providers and patients, slowing adoption of advanced vascular access solutions despite their potential benefits. This challenge necessitates continuous innovation in device design, incorporation of antimicrobial coatings, and the implementation of strict infection control protocols. Without addressing these safety concerns effectively, market growth may be hindered due to the potential for adverse events that undermine trust in vascular access procedures.
Key Market Trends
Rising Adoption of Image-Guided Vascular Access Techniques
The Global Vascular Access Procedures Market is witnessing a notable trend with the rising adoption of image-guided vascular access techniques, driven by the growing demand for precision, safety, and efficiency in medical interventions. Image-guided procedures, using ultrasound, fluoroscopy, or other imaging modalities, allow clinicians to visualize the vascular anatomy in real time, significantly reducing the risk of complications such as arterial puncture, hematoma, or catheter misplacement. This approach is particularly valuable in complex patient cases, including those with challenging vascular anatomy, pediatric patients, and individuals requiring repeated access for treatments like dialysis or chemotherapy. The integration of imaging technologies into vascular access workflows is improving first-attempt success rates, minimizing patient discomfort, and reducing procedure time, which enhances both clinical outcomes and operational efficiency in healthcare settings.
Technological advancements in portable and handheld ultrasound devices are expanding the accessibility of image-guided procedures beyond specialized centers to community hospitals and outpatient clinics. This trend is also supported by growing clinical evidence demonstrating superior safety profiles and long-term patency rates when image guidance is employed. Training initiatives and skill development programs by medical societies and device manufacturers are equipping healthcare professionals with the expertise to adopt these techniques more widely. As healthcare systems prioritize patient safety, cost-effectiveness, and adherence to evidence-based practices, the shift toward image-guided vascular access is becoming a standard of care across multiple therapeutic areas, positioning it as a critical driver of procedural evolution in the market.
In this report, the Global Vascular Access Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Vascular Access Procedures Market.
Global Vascular Access Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: